Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-25-009739
Filing Date
2025-03-21
Accepted
2025-03-21 06:12:40
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 ny20045827x1_s3.htm S-3 769161
2 EXHIBIT 1.2 ny20045827x1_ex1-2.htm EX-1.2 238574
3 EXHIBIT 4.3 ny20045827x1_ex4-3.htm EX-4.3 307049
4 EXHIBIT 4.4 ny20045827x1_ex4-4.htm EX-4.4 276758
5 EXHIBIT 5.1 ny20045827x1_ex5-1.htm EX-5.1 18172
6 EXHIBIT 5.2 ny20045827x1_ex5-2.htm EX-5.2 10071
7 EXHIBIT 23.1 ny20045827x1_ex23-1.htm EX-23.1 1796
8 FILING FEES TABLE ny20045827x1_ex107.htm EX-FILING FEES 46698
9 logo_sentibio.jpg GRAPHIC 30192
10 logo_sentibiox1.jpg GRAPHIC 33466
11 ny20045827x1_ex5-1image01.jpg GRAPHIC 2901
  Complete submission text file 0001140361-25-009739.txt   1761039
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-285985 | Film No.: 25758446
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)